Results 61 to 70 of about 140,892 (150)

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy [PDF]

open access: gold, 2022
Yanni Wang   +7 more
openalex   +1 more source

Comparison of mouse models of heart failure with reduced ejection fraction

open access: yesESC Heart Failure
Aims Heart failure with reduced ejection fraction (HFrEF) is a leading cause of death worldwide; thus, therapeutic improvements are needed. In vivo preclinical models are essential to identify molecular drug targets for future therapies.
Nabil V. Sayour   +11 more
doaj   +1 more source

Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases

open access: diamond, 2020
S. Yu. Martsevich   +7 more
openalex   +2 more sources

Could Targeted Pharmacotherapies Exert a “Disease Modification Effect” in Patients with Chronic Plaque Psoriasis? [PDF]

open access: gold, 2022
Francesco Bellinato   +4 more
openalex   +1 more source

Clinically relevant drug-drug interactions with nirmatrelvir/ritonavir in patients on chronic pharmacotherapy [PDF]

open access: diamond
Zuzana Mačeková   +8 more
openalex   +1 more source

Pharmacotherapies to prevent epidural fibrosis after laminectomy: a systematic review of in vitro and in vivo animal models [PDF]

open access: green, 2023
Venkateswaran Ganesh   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy